Skip to main content
CSTL
NASDAQ Life Sciences

Q3 Revenue Jumps 24% to $102.9M, Full-Year Guidance Raised to $385-395M

Tom Rudovsky · Reported by PR Newswire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$34.2
Mkt Cap
$1.045B
52W Low
$17.722
52W High
$44.28
52W Position info
93% above low
Off High info
23% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

CSTL sits 93% above its 52-week low of $17.722 on elevated volume (1.9× avg).

Summary

Castle delivered Q3 2026 revenue of $102.9 million, up 24% from $83.0 million a year ago, and raised full-year 2026 guidance to $385-395 million from $365-375 million. TissueCypher drove the beat with 15,574 test reports, up 47% year over year, while DecisionDx-Melanoma slipped to 10,177 reports from 10,459. Adjusted EBITDA rose to $12.7 million from $9.2 million, though GAAP net loss widened to $4.1 million ($0.13 per share) from $0.5 million, partly on a $3.4 million mark-to-market loss on equity securities. The company reaffirmed expectations for positive Adjusted EBITDA in Q4 2026, full-year 2026 and full-year 2027, backed by $277.7 million in cash and marketable securities. The guidance raise is the headline item for traders; the melanoma volume decline is the one soft spot to weigh against the TissueCypher ramp.

At the time of this announcement, CSTL was trading at $34.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $17.72 to $44.28. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CSTL - Latest Insights

CSTL
Jul 31, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $28.65
Real-time Price: $32.86 info
Change: +$4.21 (+15%) info
Market Cap: $1.013B info
CSTL
Jul 30, 2026, 4:15 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $27.99
Real-time Price: $32.86 info
Change: +$4.87 (+17%) info
Market Cap: $1.013B info
CSTL
Jul 30, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $28.48
Real-time Price: $32.86 info
Change: +$4.38 (+15%) info
Market Cap: $1.013B info
CSTL
Jul 30, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $28.83
Real-time Price: $32.86 info
Change: +$4.03 (+14%) info
Market Cap: $1.013B info
CSTL
May 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.60
Real-time Price: $32.86 info
Change: +$8.26 (+34%) info
Market Cap: $1.013B info